CCM
Consonance Capital Management Portfolio holdings
AUM
$7.28M
This Quarter Return
+12.24%
1 Year Return
-42.86%
3 Year Return
+319.33%
5 Year Return
+899.35%
10 Year Return
–
AUM
$1.41B
AUM Growth
+$1.41B
(-11%)
Cap. Flow
-$62.5M
Cap. Flow
% of AUM
-4.42%
Top 10 Holdings %
Top 10 Hldgs %
67.5%
Holding
33
New
7
Increased
5
Reduced
12
Closed
3
Top Buys
| 1 |
Iovance Biotherapeutics
IOVA
|
$116M |
| 2 |
Insmed
INSM
|
$43.8M |
| 3 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$30.9M |
| 4 |
EPZM
Epizyme, Inc
EPZM
|
$16.1M |
| 5 |
Omeros
OMER
|
$14.5M |
Top Sells
| 1 |
Myriad Genetics
MYGN
|
$110M |
| 2 |
AMRN
Amarin Corp
AMRN
|
$46.1M |
| 3 |
Pacira BioSciences
PCRX
|
$37.1M |
| 4 |
United Therapeutics
UTHR
|
$35.5M |
| 5 |
Vericel Corp
VCEL
|
$25.6M |
Sector Composition
| 1 | Healthcare | 95.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMRN
1
Amarin Corp
AMRN
$311M
| $167M | 11.82% | 8,613,823 -2,377,152 | -22% | -$46.1M |
|
2
uniQure
QURE
$896M
| $149M | 10.57% | 1,911,529 -73,931 | -4% | -$5.78M |
|
|
3
Iovance Biotherapeutics
IOVA
$807M
| $144M | 10.16% | 5,852,836 +4,712,836 | +413% | +$116M |
|
|
4
Pacira BioSciences
PCRX
$1.2B
| $122M | 8.62% | 2,799,916 -852,218 | -23% | -$37.1M |
|
5
Travere Therapeutics
TVTX
$1.56B
| $76.6M | 5.42% | 3,812,516 -219,607 | -5% | -$4.41M |
|
6
Catalyst Pharmaceutical
CPRX
$2.52B
| $68.6M | 4.86% | 17,875,655 | – | – |
|
|
7
United Therapeutics
UTHR
$13.8B
| $60.2M | 4.26% | 770,769 -454,618 | -37% | -$35.5M |
|
|
EPZM
8
DELISTED
Epizyme, Inc
EPZM
| $59.7M | 4.23% | 4,760,059 +1,281,798 | +37% | +$16.1M |
|
|
9
Vericel Corp
VCEL
$1.83B
| $55.4M | 3.92% | 2,932,152 -1,355,940 | -32% | -$25.6M |
|
10
UroGen Pharma
URGN
$900M
| $51.5M | 3.65% | 1,433,774 -325,550 | -19% | -$11.7M |
|
11
Vanda Pharmaceuticals
VNDA
$279M
| $51.1M | 3.62% | 3,626,545 -631,813 | -15% | -$8.9M |
|
|
12
Omeros
OMER
$283M
| $47.9M | 3.39% | 3,051,922 +927,303 | +44% | +$14.5M |
|
|
AERI
13
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $44.5M | 3.15% | 1,506,695 -190,078 | -11% | -$5.62M |
|
|
14
Insmed
INSM
$28.8B
| $43.8M | 3.1% | +1,711,150 | New | +$43.8M |
|
15
Karyopharm Therapeutics
KPTI
$61.7M
| $34.8M | 2.46% | 5,803,227 +644,343 | +12% | +$3.86M |
|
|
OXFD
16
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $32.2M | 2.28% | 2,343,524 -265,260 | -10% | -$3.65M |
|
17
Corcept Therapeutics
CORT
$7.35B
| $32.1M | 2.27% | 2,882,773 -864,680 | -23% | -$9.64M |
|
|
ICPT
18
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $30.9M | 2.19% | +388,470 | New | +$30.9M |
|
19
Aurinia Pharmaceuticals
AUPH
$1.58B
| $27.8M | 1.97% | 4,222,558 | – | – |
|
|
KDMN
20
DELISTED
Kadmon Holdings, Inc.
KDMN
| $24M | 1.7% | 11,627,900 | – | – |
|
21
ADMA Biologics
ADMA
$4.12B
| $22.1M | 1.56% | 5,705,352 +1,117,000 | +24% | +$4.32M |
|
|
CCXI
22
DELISTED
ChemoCentryx, Inc.
CCXI
| $15.5M | 1.1% | 1,666,667 | – | – |
|
23
STAAR Surgical
STAA
$1.36B
| $14.2M | 1.01% | +484,557 | New | +$14.2M |
|
24
Mustang Bio
MBIO
$10.9M
| $12.4M | 0.88% | +3,375,000 | New | +$12.4M |
|
25
ANI Pharmaceuticals
ANIP
$2.03B
| $11.8M | 0.83% | 142,943 | – | – |
|